135 related articles for article (PubMed ID: 9539581)
21. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
22. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
[TBL] [Abstract][Full Text] [Related]
24. The use of anisotropic data in 125I prostate implants.
Fox RA; Haworth A; Mina LL
Australas Phys Eng Sci Med; 1997 Jun; 20(2):57-63. PubMed ID: 9262024
[TBL] [Abstract][Full Text] [Related]
25. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
26. Loading technique comparison in permanent 125I prostate implants.
Williams BV; Horton J; Lawyer A; Chapman J
Med Dosim; 1999; 24(4):273-7. PubMed ID: 10643736
[TBL] [Abstract][Full Text] [Related]
27. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
29. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
30. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
[TBL] [Abstract][Full Text] [Related]
31. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
Nuttens VE; Lucas S
Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
[TBL] [Abstract][Full Text] [Related]
32. CT-based dosimetry for transperineal I-125 prostate brachytherapy.
Willins J; Wallner K
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):347-53. PubMed ID: 9308938
[TBL] [Abstract][Full Text] [Related]
33. Recommendations for intraoperative mesh brachytherapy: Report of AAPM Task Group No. 222.
Feng W; Rivard MJ; Carey EM; Hearn RA; Pai S; Nath R; Kim Y; Thomason CL; Boyce DE; Zhang H
Med Phys; 2021 Nov; 48(11):e969-e990. PubMed ID: 34431524
[TBL] [Abstract][Full Text] [Related]
34. [Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].
Cosset JM; Hannoun-Lévi JM; Peiffert D; Delannes M; Pommier P; Pierrat N; Nickers P; Thomas L; Chauveinc L
Cancer Radiother; 2013 Apr; 17(2):111-7. PubMed ID: 23478488
[TBL] [Abstract][Full Text] [Related]
35. Mathematical formulation of
Mostaghimi H; Mehdizadeh AR; Darvish L; Akbari S; Rezaei H
J Cancer Res Ther; 2017; 13(3):436-441. PubMed ID: 28862205
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
[TBL] [Abstract][Full Text] [Related]
37. Prostate brachytherapy: comparison of dose distribution with different 125I source designs.
Beyer DC; Puente F; Rogers KL; Gurgoze EM
Radiology; 2001 Dec; 221(3):623-7. PubMed ID: 11719655
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.
Vicini FA; Kini VR; Edmundson G; Gustafson GS; Stromberg J; Martinez A
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):483-91. PubMed ID: 10348275
[TBL] [Abstract][Full Text] [Related]
39. [Validation of calculation method for dose distribution around radioactive iodine-125 particles based on AAPM TG43 report].
Tian SQ; Wang JJ; Ji Z; Jiang YL; Qiu B; Fan JH; Sun HT
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(3):199-204. PubMed ID: 36649991
[No Abstract] [Full Text] [Related]
40. Supplement to the 2004 update of the AAPM Task Group No. 43 Report.
Rivard MJ; Butler WM; DeWerd LA; Huq MS; Ibbott GS; Meigooni AS; Melhus CS; Mitch MG; Nath R; Williamson JF;
Med Phys; 2007 Jun; 34(6):2187-205. PubMed ID: 17654921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
